Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage
Herbert M. Pinedo(Amsterdam University Medical Centers), Giuseppe Giaccone(Georgetown University), Alexandre E. Voskuyl(Vrije Universiteit Amsterdam), Nobusuke Nishi(Kirin (Japan)), Martine Reijm(Vrije Universiteit Amsterdam), Paul Lips(Vrije Universiteit Amsterdam), Alfons J.M. van den Eertwegh(Amsterdam University Medical Centers), Chris H. Polman(Vrije Universiteit Amsterdam), B. Mary E. von Blomberg(Vrije Universiteit Amsterdam), Rik J. Scheper(The Netherlands Cancer Institute), Thomas Rustemeyer(Vrije Universiteit Amsterdam), Ad A. van Bodegraven(Vrije Universiteit Amsterdam)
Cited by 270
Related Papers
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1
|Journal of Clinical Oncology|2004|1.7k
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2009|913
Fluorouracil: biochemistry and pharmacology.
|Journal of Clinical Oncology|1988|834
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726